Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

This study has been completed.

Sponsors and Collaborators:	National Center for Research Resources (NCRR) Children's Hospital of Philadelphia
Information provided by:	National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier:	NCT00008736

Purpose

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Condition	Intervention	Phase
Infant, Newborn, Diseases	Drug: metoclopramide	Phase II

MedlinePlus related topics: Premature Babies

Drug Information available for: Metoclopramide Metoclopramide hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized
Official Title:	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Eligibility

Ages Eligible for Study:	up to 1 Month
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00008736

Locations

United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104

Sponsors and Collaborators

National Center for Research Resources (NCRR)

Children's Hospital of Philadelphia

More Information

Study ID Numbers:	NCRR-M01RR00240-1724
Study First Received:	January 16, 2001
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00008736
Health Authority:	United States: Federal Government

Keywords provided by National Center for Research Resources (NCRR):

Feeding intolerance
Infant, premature

Study placed in the following topic categories:

Dopamine
Infant, Newborn, Diseases
Metoclopramide

Additional relevant MeSH terms:

Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Autonomic Agents
Therapeutic Uses
Physiological Effects of Drugs
Gastrointestinal Agents

Antiemetics
Dopamine Agents
Dopamine Antagonists
Peripheral Nervous System Agents
Central Nervous System Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009